New hope for breast cancer patients when standard drugs fail
NCT ID NCT06702618
First seen Apr 11, 2026 · Last updated Apr 11, 2026
Summary
This study is testing whether adding a new drug called TQB3616 to standard hormone therapy can help control advanced breast cancer that has stopped responding to commonly used CDK4/6 inhibitor medications. The trial involves 33 women whose cancer has returned or spread despite previous treatment. Researchers will measure how well the combination shrinks tumors and controls cancer growth while monitoring side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute, Shandong Cancer Hospital)
Jinan, Shandong, 250117, China
-
Hai'an People's Hospital
Nantong, Jiangsu, 226600, China
-
Harbin Medical University Cancer Hostipal
Harbin, Heilongjiang, 150000, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410010, China
-
Jiangmen Central Hospital
Jiangmen, Guangdong, 529000, China
-
Jiangsu Provincial People's Hospital
Nanjing, Jiangsu, 210003, China
-
Liaoning Cancer Hospital
Shenyang, Liaoning, 110000, China
-
Luohe Central Hospital
Luohe, Henan, 462000, China
-
The Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, 646000, China
-
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi’an, Shanxi, 710061, China
-
The First Affilliated Hospital of Bengbu Medical University
Bengbu, Anhui, 233000, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, 300202, China
-
Xingtai People's Hospital
Xingtai, Hebei, 54000, China
Conditions
Explore the condition pages connected to this study.